Simple and safe digitoxin dosing in heart failure based on data from the DIGIT-HF trial

BACKGROUND: The present study aimed to develop a simple dosing score when starting the cardiac glycoside digitoxin in heart failure with reduced ejection fraction (HFrEF) employing first data from the randomized, double-blinded DIGIT-HF trial. METHODS AND RESULTS: In DIGIT-HF, digitoxin was started...

Descripción completa

Detalles Bibliográficos
Autores principales: Bavendiek, Udo, Großhennig, Anika, Schwab, Johannes, Berliner, Dominik, Liu, Xiaofei, Maier, Lars, Gaspar, Thomas, Rieth, Andreas, Philipp, Sebastian, Hambrecht, Rainer, Westenfeld, Ralf, Münzel, Thomas, Winkler, Sebastian, Hülsmann, Martin, Westermann, Dirk, Zdravkovic, Marja, Lichtinghagen, Ralf, von der Leyen, Heiko, Zimmermann, Silke, Veltmann, Christian, Böhm, Michael, Störk, Stefan, Koch, Armin, Bauersachs, Johann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359203/
https://www.ncbi.nlm.nih.gov/pubmed/37087503
http://dx.doi.org/10.1007/s00392-023-02199-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359203/
https://www.ncbi.nlm.nih.gov/pubmed/37087503
http://dx.doi.org/10.1007/s00392-023-02199-z

Ejemplares similares